DUBLIN, August 21, 2026, 06:25 IST — Publix’s Class I recall of frozen blueberries is again drawing attention to Chile’s berry oversight. Dole plc NYSE:DOLE investors now face margin pressure concerns rather than any confirmed product liability exposure.
Dole was excluded from both the recall and the associated outbreak. The GreenWise products in question originated from Frutas y Hortalizas del Sur, a private supplier based in Chile. This distinction is significant.
The broader implications remain pertinent. Dole cultivates and ships blueberries from Chile, and increased fruit sourcing expenses have already reduced its second-quarter profit margins. Any disruption in another part of Chile could restrict supply or push compliance expenses higher, without delivering a significant boost in revenue.
| Recall measure | Verified figure | Investor relevance |
|---|---|---|
| Products | 4 GreenWise frozen berry SKUs | Entire production recalled |
| Retail footprint | 8 U.S. states | Publix recall limited to several regions |
| Reported cases | 12 | Investigation into outbreak ongoing |
| Hospitalisations | 4 | There have not been any fatalities |
| Units reported | About 182,000 | Includes both 10-ounce and 48-ounce varieties |
The FDA associated 12 cases of illness in Florida and Georgia with the outbreak strain. Four individuals required hospital treatment. The agency reported that seven out of nine interviewed patients had eaten frozen blueberries, with five identifying GreenWise products purchased at Publix.
Reports indicate the recall involves about 182,000 units. Initial estimates put the affected weight between 113,750 pounds and 546,000 pounds, depending if all units were from the smallest or largest packaged sizes. The actual amount is within that range.
The scope of regulatory action extends beyond the recall of the store products. The FDA has included Frutas y Hortalizas del Sur, Comfrut SA, and associated berry items on Import Alert 99-35, meaning that shipments could be held without physical inspection. Dole does not appear on this alert.
| Dole measure | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $2.499 billion | $2.428 billion | up 2.9% |
| Gross profit | $195.3 million | $218.3 million | down 10.5% |
| Gross margin | 7.81% | 8.99% | lower by 1.18 points |
| Adjusted EBITDA | $116.8 million | $137.1 million | down 14.8% |
| Adjusted diluted EPS | $0.46 | $0.55 | down 16.4% |
Dole’s latest quarter highlights the impact minor sourcing disruptions can have. Revenue increased by 2.9%, but the gross margin declined 1.18 percentage points on a calculated basis. Adjusted EBITDA was down 14.8% as costs for fruit, fuel and shipping climbed.
Dole’s diversified business provides balance. Revenue from the Americas and the rest of the world increased by 13.9%, and adjusted EBITDA climbed 33.8%. Management attributed the results to higher North American volumes and improvements tied to a fourth-quarter restructuring in berry operations.
| Operating signal | Latest disclosure | Read-through |
|---|---|---|
| Americas/ROW revenue | +13.9% year on year | Growth driven by stronger pricing and volume |
| Americas/ROW adjusted EBITDA | +33.8% | Improvement linked to Berry restructuring |
| Fresh Fruit adjusted EBITDA | -30.9% | Costs for shipping and sourcing increased |
| 2026 adjusted EBITDA outlook | About $400 million | Outlook unchanged |
| Quarterly dividend | $0.085 a share | To be paid on October 7 |
Executive Chairman Carl McCann stated that Dole produced results “in line with our expectations.” The 2026 adjusted EBITDA target remains close to $400 million. The guidance is unchanged by the recall.
Dole’s operations in Chile offer direct access to blueberry production. According to the company, Chile exports blueberries primarily to overseas markets, with the United States traditionally serving as the largest buyer. This could benefit Dole through stronger pricing, but also means the company faces increased scrutiny.
| Analyst source | Recommendation | Analysts | Average target |
|---|---|---|---|
| S&P Global via StockAnalysis | Buy | 4 | $17.44 |
| MarketBeat | Hold | 4 | $15.50 |
| Investing.com poll | Buy | 4 | $17.69 |
| Deutsche Bank, August 11 | Hold | 1 | $14.00 |
Analyst opinions vary. According to StockAnalysis, S&P Global data indicated a Buy rating and a $17.44 price target. MarketBeat listed a Hold consensus and a $15.50 target. Following earnings, Deutsche Bank maintained its Hold recommendation but reduced its target to $14.
Dole ended the most recent session at $12.92 as of August 18, 16:00 EDT, according to the latest official closing data. The stock traded 22% under its 52-week peak of $16.57. U.S. markets were shut when this was published.
Risks: The exact volume recalled has not been specified, and there is no indication that Dole is connected to the outbreak. Import restrictions may continue to apply only to designated suppliers. As a result, blueberry prices might not be significantly affected, while Dole’s primary risks continue to be fuel, shipping, and sourcing costs for fruit.
The investor test is specific. A minor berry shortfall would not significantly impact a $2.5 billion quarterly revenue total. However, it could still reveal how sensitive slim produce margins are when supply chains experience pressure.
Related articles: Stock Market
